openPR Logo
Press release

Immunosuppressive Drugs Market Size Value, Share Estimation, Growth Trends and Industry Insights

12-17-2020 07:26 PM CET | Health & Medicine

Press release from: Market Research Future

Immunosuppressive Drugs Market

Immunosuppressive Drugs Market

Immunosuppressive Drugs Market Size, Trends and Share Analysis By Drug Type (Calcineurin Inhibitors, Corticosteroids, Antiproliferative Agents, mTOR Inhibitors, Others), By Route of Administration (Intravenous, Oral, Others), By Application (Autoimmune Disease, Organ Transplant, Kidney Transplant, Heart Transplant, Others) and By End User (Hospitals and Clinics, Organ Transplant Centers, Others) – Forecast to 2025

Immunosuppressive Drugs Market Overview

MRFR (Market Research Future) projects exciting prospects for the immunosuppressive drugs market size to cross USD 1.39 Billion by 2025. It is also presumed that the market size can burgeon at a rate of 4.63% between 2019 and 2025 (analysis period). We will provide COVID-19 impact analysis with the report, along with all the extensive key developments in the market post the coronavirus disease outbreak.

The novel coronavirus has been a huge deterrent for the immunosuppressive drugs industry worldwide. Individuals dealing with chronic conditions or autoimmune diseases are believed to be extremely vulnerable to the SARS-CoV-2 infection. Even the elderly patients are at high risk of being affected by the pandemic. But, the COVID-19 impact on the organ transplantation industry has been substantially brutal, emerging as a life-threatening event for organ transplant recipients.

Request Free Sample Copy of the report “Immunosuppressive Drugs Market Research Report - Global Forecast till 2025” at: https://www.marketresearchfuture.com/sample_request/8228

Despite the worldwide lockdown, the COVID-19 has been spreading exponentially and has been significantly restricting the transplantation system in the highly affected locations owing to the extreme chances of SARS-CoV-2 among immunosuppressed patients, transmission risks among healthcare staff and more. Also, travel bans have been unfavorable for organ procurement organizations/OPOs and, have led to shortage of medical services across the world, be it developed or developing nations.

Increase in organ transplantation across the globe has been the result of the rising burden of various genetic conditions such as heart defect, polycystic kidney disease and cystic fibrosis. Rise in hepatitis cases, damaged organs owing chronic disorders such as diabetes and physical injuries are some of the other growth boosters for organ transplants, leading to higher need for immunosuppressive drugs. These drugs come into the picture after the organ transplant procedure, helping patient's immune system deal with the hyper-immune response. In a nutshell, the escalating need for organ transplantation procedures across the world has bolstered the demand for effective immunosuppressive drugs and could be favorable for the global market in the following years.

With the amplifying demand for transplantation and the rising frequency of technological innovations in organ transplants as well as tissue engineering, the market is bound to expand significantly in the next few years. From the competitive standpoint, various players are undertaking strategies such as business expansions, collaborations and product advancement, to gain leverage in the global market. Increasing green light from the FDA is also encouraging top players to come up with more efficient drugs in the market. To cite an instance, in November 2020, Lupin, in collaboration with Concord Biotech, got the approval from FDA to sell Tacrolimus capsules, generic immunosuppressive drugs, in the US market. These capsules help treat organ rejection in pediatric and adult patients that are undergoing allogeneic kidney, heart or liver transplants, combined with various other immunosuppressant drugs.

Immunosuppressive Drugs Market Opportunities

Pharmaceutical and biopharmaceutical firms are spending considerably on R&D activities in terms of immunosuppressive drugs, which helps boost the market’s growth potential. Additionally, substantial demand for highly reliable and efficient immunosuppressive drugs for treating chronic autoimmune disorders and avoiding organ rejection in individuals undergoing organ transplantation could be a lucrative opportunity for the key contenders in the global market.

Immunosuppressive Drugs Market Segmental Analysis

Immunosuppressive drugs market has been categorized on the basis of drug type, route of administration, application, and end user.

The drug types considered in the market study include IMDH inhibitors, corticosteroids, calcineurin inhibitors, mTOR inhibitors, antiproliferative agents, and others. The calcineurin inhibitors segment will most like take the lead in the global market, given their high efficacy and the resultant rise in the demand for these drugs post organ transplantation procedures. The corticosteroids segment can however, secure the fastest advancement rate since healthcare professionals are progressively opting for these drugs.

The main routes of administration are oral, intravenous, and more. Intravenous route of administration could emerge as the biggest segment while the oral route can be the fastest expanding segment.

Immunosuppressive drugs’ key applications are organ transplant, autoimmune disease, and others. Autoimmune diseases should be the top segment in the coming years on account of the rising cases of autoimmune disorders including multiple sclerosis, systemic lupus erythematosus and rheumatoid arthritis. On the other hand, the highest growth rate will be secured by the organ transplant segment, given the expanding pool of transplant donors along with the surge in organ transplantations.

The key market end-users can be organ transplant centers, hospitals and clinics, and others. The hospitals and clinics category is likely to obtain the leading position owing to the significant rise in patient admissions combined with the growth in the number of hospitals, especially in emerging countries. The organ transplant centers segment could leap ahead at the highest growth rate, as the deployment of immunosuppressants after the transplant procedures is increasing at a promising rate.

Immunosuppressive Drugs Market Regional Study

Europe and APAC/Asia Pacific along with Americas and MEA/Middle East and Africa are the primary markets for immunosuppressive drugs across the world.

With the highest number of organs transplants every year and significant burden of autoimmune diseases, it is no surprise that America has taken the lead in the immunosuppressive drug market. Frequent technical advances and considerable spending on extensive R&D can also be credited for the strong market growth in the region. Large-scale government funding, and the well-developed healthcare infrastructure along with a huge pool of skilled medical professionals also add to the market value.

Despite a lower burden of autoimmune diseases compared to Europe and the Americas, the exploding population and the surging need for organ transplants boost APAC’s chances of achieving the fastest growth rate in the coming years. Low healthcare costs could be one of the reasons for the recent surge in medical tourism, which has furthered the need for effective immunosuppressive drugs. Also, encouraging government initiatives in the form of large-scale funding and rising focus of the manufacturers on research and development activities are a few unexplored avenues that could translate to high revenues in the ensuing years.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/immunosuppressive-drugs-market-8228

Immunosuppressive Drugs Market Key Companies

The key companies operative in the worldwide market are Glenmark Pharmaceuticals, Inc (India), Genzyme Co. (US), Zydus Cadila (India), Novartis AG (Switzerland), Pfizer Inc. (US), Actavis, Inc. (US), Mylan Laboratories Inc. (US), F. Hoffmann-La Roche AG (Switzerland), Accord Healthcare (US), Astellas Pharma (Japan), Bristol-Myers Squibb Company (US), GlaxoSmithKline PLC (UK), to mention a few.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immunosuppressive Drugs Market Size Value, Share Estimation, Growth Trends and Industry Insights here

News-ID: 2212588 • Views:

More Releases from Market Research Future

Navigating Schizophrenia Care Market Expected to Expand to $8.06 Billion by 2030 | Johnson & Johnson, AstraZeneca, Eli Lilly, Alkermes
Navigating Schizophrenia Care Market Expected to Expand to $8.06 Billion by 2030 …
Schizophrenia Market Overview - The Schizophrenia Market Size was assessed at USD 5.5 billion in 2022 and is expected to expand from USD 5.76 billion in 2023 to USD 8.06 billion by 2030, with a compound annual growth rate (CAGR) of 4.9% during the forecast period (2023- 2030). The schizophrenia market is a significant segment within the pharmaceutical and mental healthcare industries, focused on addressing the complex needs of individuals living with
Revolutionizing Healing: Skin Graft Market Set to Grow at 7.01% CAGR, Reaching $7.36 Billion by 2032
Revolutionizing Healing: Skin Graft Market Set to Grow at 7.01% CAGR, Reaching $ …
Skin Graft Market Overview - In 2022, the skin graft market was estimated at USD 4.00 billion. The skin graft market is expected to increase from USD 4.28 billion in 2023 to USD 7.36 billion by 2032, with a compound annual growth rate (CAGR) of 7.01% over the forecast period (2023-2032). The skin graft market plays a crucial role in the field of dermatology and wound care, providing solutions for patients with
Medical Suction Device Market Size to Exceed USD 1.80 billion by 2032, with a Robust CAGR of 4.8%
Medical Suction Device Market Size to Exceed USD 1.80 billion by 2032, with a Ro …
Medical Suction Device Market Overview - The Medical Suction Device Market was valued at USD 0.92 billion in 2021. The Medical Suction Device Market is expected to increase from USD 0.96 billion in 2022 to USD 1.80 billion by 2032, with a compound yearly growth rate (CAGR) of 4.8% over the forecast period (2023-2032). The medical suction device market plays a vital role in healthcare settings by providing efficient suction for various
Agriculture Phosphate Fertilizer Market Poised for Growth Despite Sustainability Concerns
Agriculture Phosphate Fertilizer Market Poised for Growth Despite Sustainability …
Phosphate fertilizers Market Outlook Phosphate fertilizers are the cornerstone of modern agriculture, providing crops with the essential nutrient phosphorus (P) needed for healthy growth and development. As the global population continues to rise, so does the demand for food, driving the phosphate fertilizer market towards significant growth. According to a report by Market Research Future (MRFR), the market is expected to reach a value of USD 104.02 billion by 2032, with

All 5 Releases


More Releases for Immunosuppressive

Immunosuppressive Agents Market Size, Share, Industry, Analysis, Growth, Report …
The Global Immunosuppressive Agents Market 2021 by Regions, Type, and Application, forecast to 2027 research report is a comprehensive, methodical, and all-encompassing examination of the industry. The study's goal is to help key vendors, organisations, and end-users in the industry better grasp the benefits and complete features of market segments. It examines market dynamics and gives an overview to aid in the definition, categorization, and statistical analysis of markets. The
New Report: Immunosuppressive Drug Market Size, Growth Analysis Report, Forecast …
The global immunosuppressive drug market is anticipated to grow at a considerable CAGR of 14.2% during the forecast period (2021-2027). The immunosuppressive drug is used to slow down the response of the immune system so that the organ does not get rejected by the body. The drug prevents the transplanted organ from getting damaged by the body. (Get 15% Discount on Buying this Report) Get Report Sample Copy @ https://www.omrglobal.com/request-sample/immunosuppressive-drug-market The market
Immunosuppressive Drug Market 2019: Size, Share, Demand, Trends, Growth and 2023 …
Global Immunosuppressive Drug Industry New Study On “2019-2023 Immunosuppressive Drug Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database Immunosuppressive drugs are used for the treatment of end-stage organ replacement or failure. These drugs are anti-rejection drugs used to make the body less likely to reject a transplanted organ, such as a liver, heart, or kidney. Increasing incidence of chronic ailments and the demand for
Global Organ Transplantation Immunosuppressive Drug Market Status, Application, …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Organ Transplantation Immunosuppressive Drug Market Size, Status and Forecast 2025” provides an in-depth analysis of the Organ Transplantation Immunosuppressive Drug with the forecast of market size and growth. The analysis includes addressable market, market by volume, and market share by business type and by segment (external and in-house).The research study
Global Organ Transplantation Immunosuppressive Drug Market By Growth, Forecast, …
Qyresearchreports include new market research report Global Organ Transplantation Immunosuppressive Drug Market SizeStatus and Forecast 2025 to its huge collection of research reports. This report studies the global Organ Transplantation Immunosuppressive Drug market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Organ Transplantation Immunosuppressive Drug market by companies, region, type and end-use industry. In 2017, the global Organ Transplantation Immunosuppressive Drug market size was
A Comprehensive Study exploring Organ Transplantation Immunosuppressive Drug Mar …
HTF MI published a new industry research that focuses on Organ Transplantation Immunosuppressive Drug market and delivers in-depth market analysis and future prospects of Global Organ Transplantation Immunosuppressive Drug market. The study covers significant data which makes the research document a handy resource for managers, analysts, industry experts and other key people get ready-to-access and self-analyzed study along with graphs and tables to help understand market trends, drivers and market